Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008
- Autores:
-
Perdomo A., Iván A.
Nieto, Víctor Hugo
Mejía, Rossana
Ruiz, Oscar
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2009
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2440
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2440
https://doi.org/10.31260/RepertMedCir.v18.n3.2009.546
- Palabra clave:
- artritis reumatoidea
terapia biológica
infliximab
factores de necrosis tumoral
rheumatoid arthritis
biological therapy
infliximab
tumor necrosis factors
- Rights
- openAccess
- License
- Fundación Universitaria de Ciencias de la Salud FUCS - 0
| id |
FUCS2_0a8b661abda6eeb2b27df8d0f284facc |
|---|---|
| oai_identifier_str |
oai:repositorio.fucsalud.edu.co:001/2440 |
| network_acronym_str |
FUCS2 |
| network_name_str |
Repositorio Digital Institucional ReDi |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| dc.title.translated.eng.fl_str_mv |
Clinical outcomes in rheumatoid arthritis treated with infliximab: Hospital de San José, 2007-2008 |
| title |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| spellingShingle |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 artritis reumatoidea terapia biológica infliximab factores de necrosis tumoral rheumatoid arthritis biological therapy infliximab tumor necrosis factors |
| title_short |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| title_full |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| title_fullStr |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| title_full_unstemmed |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| title_sort |
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008 |
| dc.creator.fl_str_mv |
Perdomo A., Iván A. Nieto, Víctor Hugo Mejía, Rossana Ruiz, Oscar |
| dc.contributor.author.spa.fl_str_mv |
Perdomo A., Iván A. Nieto, Víctor Hugo Mejía, Rossana Ruiz, Oscar |
| dc.subject.spa.fl_str_mv |
artritis reumatoidea terapia biológica infliximab factores de necrosis tumoral |
| topic |
artritis reumatoidea terapia biológica infliximab factores de necrosis tumoral rheumatoid arthritis biological therapy infliximab tumor necrosis factors |
| dc.subject.eng.fl_str_mv |
rheumatoid arthritis biological therapy infliximab tumor necrosis factors |
| publishDate |
2009 |
| dc.date.accessioned.none.fl_str_mv |
2009-09-01 00:00:00 2022-02-21T20:37:32Z |
| dc.date.issued.none.fl_str_mv |
2009-09-01 |
| dc.date.available.none.fl_str_mv |
2009-09-01 00:00:00 2022-02-21T20:37:32Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.eng.fl_str_mv |
Journal article |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
10.31260/RepertMedCir.v18.n3.2009.546 |
| dc.identifier.issn.none.fl_str_mv |
0121-7372 |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.fucsalud.edu.co/handle/001/2440 |
| dc.identifier.eissn.none.fl_str_mv |
2462-991X |
| dc.identifier.url.none.fl_str_mv |
https://doi.org/10.31260/RepertMedCir.v18.n3.2009.546 |
| identifier_str_mv |
10.31260/RepertMedCir.v18.n3.2009.546 0121-7372 2462-991X |
| url |
https://repositorio.fucsalud.edu.co/handle/001/2440 https://doi.org/10.31260/RepertMedCir.v18.n3.2009.546 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.references.spa.fl_str_mv |
Ducoulombier V, Solau E, Coquerelle P. Long – term results of Infliximab therapy in rheumatoid arthritis: Experience acquired by the North-Pas-de-Calais hospital network . Joint Bone Spine. 2007 Jan;74(1):56-9 Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1594-602. Godinho F, Godfrin B. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30. Williams RO. Pathogenesis and therapy of rheumatoid arthritis. Ernst Schering Found Symp Proc. 2006; 1:107-30. Asociación Colombiana de Reumatología. Grupo de Expertos. Primer consenso colombiano sobre el tratamiento de la artritis reumatoide temprana. Rev. Colomb.Reumatol. 2002 diciembre; 9(4): 323-31. Simon LS. The treatment of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2004 Aug;18(4):507-38 Strady C, Brochot P, Ainine K, Jegou J, Remy G, Eschard JP, Jaussaud R. [Tuberculosis during treatment by TNFalpha-inhibitors]. Presse Med. 2006 Nov; 35(11 Pt 2):1765-72. Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, Shatin D, Saag KG. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumour necrosis factor alpha antagonists. Arthritis Rheum. 2007 Apr; 56(4):1125-33. Godinho F, Godfrin B, El Mahou S, Navaux F, Zabraniecki L, Cantagrel A. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30. Cunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003 Apr;17(2):345-63. Siddiqui MA. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol. 2007 19 (3): 308-13. Askling J, Dixon W. The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis Curr Opin Rheumatol. 2008 Mar; 20(2):138-44. Case JP. Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective Part 1: The Older Drugs American Journal of Therapeutics 2001 8, 123–143. John P. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther. 2001 Mar-Apr; 8(2):123-43. Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64. Buch MH, Bingham SJ, Bryer D, Emery P. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford). 2007 Jul; 46(7):1153-6. Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006 Sep 15; 43(6):717-22. Maillard H, Ornetti P, Grimault L, Ramon JF, Ducamp SM, Saidani T, Tavernier C, Maillefert JF. Severe pyogenic infections in patients taking infliximab: a regional cohort study. Joint Bone Spine. 2005 Jul; 72(4):330-4. Fuentealba C. ¿Cómo se debe evaluar al paciente con artritis reumatoide en la práctica clínica?. Reumatología. 2003; 19(4):190-93. |
| dc.relation.bitstream.none.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/546/586 |
| dc.relation.citationedition.spa.fl_str_mv |
Núm. 3 , Año 2009 : Julio - Septiembre |
| dc.relation.citationendpage.none.fl_str_mv |
151 |
| dc.relation.citationissue.spa.fl_str_mv |
3 |
| dc.relation.citationstartpage.none.fl_str_mv |
144 |
| dc.relation.citationvolume.spa.fl_str_mv |
18 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Revista Repertorio de Medicina y Cirugía |
| dc.rights.spa.fl_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| dc.source.spa.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/546 |
| institution |
Fundación Universitaria de Ciencias de la Salud - FUCS |
| bitstream.url.fl_str_mv |
https://repositorio.fucsalud.edu.co/bitstreams/8aef7768-1368-4ccd-a912-b71ea34f0aad/download |
| bitstream.checksum.fl_str_mv |
61c827299529c3592f360d44a7fad065 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
| repository.name.fl_str_mv |
Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud |
| repository.mail.fl_str_mv |
redi@fucsalud.edu.co |
| _version_ |
1814355572068188160 |
| spelling |
Perdomo A., Iván A.9d28e08f9f0f5a763014586d3532e677300Nieto, Víctor Hugo4c0b21f235187892227dd64438ae9cb2300Mejía, Rossana075999aa1796d3573e804160e0eb3b33500Ruiz, Oscard822138782de18441c586d49d556fd772009-09-01 00:00:002022-02-21T20:37:32Z2009-09-012009-09-01 00:00:002022-02-21T20:37:32ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/546artritis reumatoideaterapia biológicainfliximabfactores de necrosis tumoralrheumatoid arthritisbiological therapyinfliximabtumor necrosis factorsDesenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008Clinical outcomes in rheumatoid arthritis treated with infliximab: Hospital de San José, 2007-2008application/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v18.n3.2009.5460121-7372https://repositorio.fucsalud.edu.co/handle/001/24402462-991Xhttps://doi.org/10.31260/RepertMedCir.v18.n3.2009.546spaDucoulombier V, Solau E, Coquerelle P. Long – term results of Infliximab therapy in rheumatoid arthritis: Experience acquired by the North-Pas-de-Calais hospital network . Joint Bone Spine. 2007 Jan;74(1):56-9Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1594-602.Godinho F, Godfrin B. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30.Williams RO. Pathogenesis and therapy of rheumatoid arthritis. Ernst Schering Found Symp Proc. 2006; 1:107-30.Asociación Colombiana de Reumatología. Grupo de Expertos. Primer consenso colombiano sobre el tratamiento de la artritis reumatoide temprana. Rev. Colomb.Reumatol. 2002 diciembre; 9(4): 323-31.Simon LS. The treatment of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2004 Aug;18(4):507-38Strady C, Brochot P, Ainine K, Jegou J, Remy G, Eschard JP, Jaussaud R. [Tuberculosis during treatment by TNFalpha-inhibitors]. Presse Med. 2006 Nov; 35(11 Pt 2):1765-72.Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, Shatin D, Saag KG. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumour necrosis factor alpha antagonists. Arthritis Rheum. 2007 Apr; 56(4):1125-33.Godinho F, Godfrin B, El Mahou S, Navaux F, Zabraniecki L, Cantagrel A. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30.Cunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003 Apr;17(2):345-63.Siddiqui MA. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol. 2007 19 (3): 308-13.Askling J, Dixon W. The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis Curr Opin Rheumatol. 2008 Mar; 20(2):138-44.Case JP. Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective Part 1: The Older Drugs American Journal of Therapeutics 2001 8, 123–143.John P. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther. 2001 Mar-Apr; 8(2):123-43.Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64.Buch MH, Bingham SJ, Bryer D, Emery P. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford). 2007 Jul; 46(7):1153-6.Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006 Sep 15; 43(6):717-22.Maillard H, Ornetti P, Grimault L, Ramon JF, Ducamp SM, Saidani T, Tavernier C, Maillefert JF. Severe pyogenic infections in patients taking infliximab: a regional cohort study. Joint Bone Spine. 2005 Jul; 72(4):330-4.Fuentealba C. ¿Cómo se debe evaluar al paciente con artritis reumatoide en la práctica clínica?. Reumatología. 2003; 19(4):190-93.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/546/586Núm. 3 , Año 2009 : Julio - Septiembre151314418Revista Repertorio de Medicina y CirugíaOREORE.xmltext/xml2578https://repositorio.fucsalud.edu.co/bitstreams/8aef7768-1368-4ccd-a912-b71ea34f0aad/download61c827299529c3592f360d44a7fad065MD51001/2440oai:repositorio.fucsalud.edu.co:001/24402022-02-21 15:37:32.453https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co |